Hollow Fiber Bioreactor: New Development for the Study of Contrast Agent Transport into Hepatocytes by Magnetic Resonance Imaging

Biotechnology and Bioengineering

Volumn 85, Issue 6, 2004, Pages 656-665

  Planchamp, Corinne ^a   Ivancevic, Marko K ^a   Pastor, Catherine M ^a   Vallée, Jean Paul ^a   Pochon, Sibylle ^b   Terrier, François ^a   Mayer, Joachim M ^c   Reist, Marianne ^c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Bracco Suisse SA   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Contrast agent; Gd BOPTA; Hepatocyte; Hollow fiber bioreactor; Magnetic resonance imaging; Transport

Indexed keywords

ADSORPTION; MAGNETIC RESONANCE IMAGING; POROSITY; REACTION KINETICS;

PERFUSION SYSTEMS; SIGNAL INTENSITY (SI);

BIOREACTORS;

CALCIUM; CONTRAST MEDIUM; GADOBENATE DIMEGLUMINE; GADOBENIC ACID; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE;

ADSORPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOREACTOR; CELL ISOLATION; CELL VIABILITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEVICE; DIFFUSION; EXTRACELLULAR CALCIUM; FLOW RATE; HEATING; HOLLOW FIBER; KINETICS; LIVER CELL; MALE; MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; OXYGENATOR; PERFUSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BIOREACTORS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CELLS, CULTURED; CONTRAST MEDIA; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; HEPATOCYTES; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MEMBRANES, ARTIFICIAL; ORGANOMETALLIC COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 1442277051     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/bit.20017     Document Type: Article

References (52)

1. Aime S, Cabella C, Colombatto S, Geninatti S, Gianolino E, Maggioni F. 2002. Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations. J Magn Reson Imag 16:394-406.
2. Allen JW, Hassanein T, Bhatia SN. 2001. Advance in bioartificial liver devices. Hepatology 34:447-455.
3. Colet J-M, Elst LV, Muller RN. 1998. Dynamic evaluation of the hepatic uptake of manganese-based MRI contrast agents: a 31P NMR study on the isolated perfused rat liver. J Magn Reson Imag 8:663-669.
4. Custer LM, Mullon C. 1998. Oxygen delivery to and use by primary porcine hepatocytes in the HepaAssist 2000 system for extracorporeal treatment of patients in end-stage liver failure. Adv Exp Med Biol 454:26-271.
5. De Haën C, Lorusso V, Tirone P. 1996. Hepatic transport of gadobenate dimeglumine in TR-rats. Acad Radiol 3:452-454.
6. De Haën C, La Ferla R, Maggioni F. 1999. Gadobenate dimeglumine 0.5 M solution for injection (Multihence) as contrast agent for magnetic resonance imaging of the liver: mechanistic studies in animals. J Comput Assist Tomogr 23(Suppl. 1):S169-S179.
7. Donoghue C, Brideau M, Newcomer P, Pangrle B, Dibiasio D, Walsh E, Moore S. 1992. Use of magnetic resonance imaging to analyse the performance of hollow-fiber bioreactors. Ann NY Acad Sci 665:285-300.
8. Gallez B, Bacic G, Swartz HM. 1996a. Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP. Magn Reson Med 35: 14-19.
9. Gallez B, Baudelet C, Adline J, Charbon V, Lambert DM. 1996b. The uptake of Mn-DPDP by hepatocytes is not mediated by the facilitated transport of pyridoxine. Magn Reson Imag 14:1191-1195.
10. Gamcsik MP, Forder JR, Millis KK. 1995. A versatile oxygenator and perfusion system for magnetic resonances studies. Biotechnol Bioeng 49:348-354.
11. Gillies RJ, Scherer PG, Raghunand N, Okerlund LS, Martinez-Zaguilan R, Hesterberg L, Dale BE. 1991. Iteration of hybridoma growth and productivity in hollow fiber bioreactors using 31P NMR. Magn Reson Med 18:181-192.
12. Giorgio TD, Moscioni AD, Rozga J, Demetriou AA. 1993. Mass transfer in a hollow fiber device used as a bioartificial liver. ASAIO J 39: 886-892.
13. Greengard O, Federman M, Knox WE. 1972. Cytomorphology of developing rat liver and its application to enzyme differentiation. J Cell Biol 52:261-272.
14. Gyngell ML. 1988. The application of steady-state free precession in rapid 2DFT NMR imaging: FAST and CE-FAST sequences. Magn Reson Imag 6:415-419.
15. Hahn PF, Saini S. 1998. Liver-specific MR imaging contrast agents. Radiol Clin North Am 36:287-297.
16. Hamilton RL, Berry MN, Williams MC, Severinghaus EM. 1974. A simple and inexpensive membrane "lung" for small organ perfusion. J Lipid Res 15:182-186.
17. Hammer BE, Heath CA, Mirer SD, Belfort G. 1990. Quantitative flow measurement in bioreactors by nuclear magnetic resonance imaging. Biotechnology 8:327-330.
18. Hammond AH, Fry JR. 1993. Maintenance of xenobiotic metabolism and toxicity in rat hepatocyte cultures after cell preservation at 4°. Biochem Pharmacol 46:333-335.
19. Ivancevic MK, Zimine Y, Lazeyras F, Foxall D, Vallée JP. 2001. FAST sequences optimization for contrast media pharmacokinetic quantification in tissue. J Magn Reson Imag 14:771-778.
20. Jackson LR, Trudel LJ, Fox JG, Lipman NS. 1996. Evaluation of hollow fiber bioreactors as an alternative to murine ascites production for small scale monoclonal antibody production. J Immunol Methods 189: 217-231.
21. Knazek RA, Skyler JS. 1976. Secretion of human prolactin in vitro. Proc Soc Exp Biol Med 151:561-564.
22. Knazek RA, Gullino PM, Kohler PO, Dedrick RL. 1972. Cell culture on artificial capillaries: an approach to tissue growth in vitro. Science 178: 65-67.
23. Kreutz FT, Jafarin A, Biggs DF, Suresh MR. 1997. Production of highly pure monoclonal antibodies without purification using hollow fiber bioreactor. Hybridoma 16:485-486.
24. Liu JJ, Chen BS, Tsai TF, Wu YJ, Pang VF, Hsieh A, Hsieh JH, Chang TH. 1991. Long term and large scale cultivation of human hepatoma Hep G2 cells in hollow fiber bioreactor. Cytotechnology 5:129-139.
25. Lorusso V, Arbughi T, Tirone P, De Haën C. 1999. Pharmacokinetics and tissue distribution in animals of gadobenate ion, the magnetic resonance imaging contrast enhancing component of gadobenate dimeglumine 0.5 M solution for injection (MultiHance). J Comput Assist Tomogr 23(Suppl. 1):181-194.
26. Macdonald JM, Grillo M, Schmidlin O, Tajiri DT, James TL. 1998. NMR spectroscopy and MRI investigation of a potential bioartificial liver. NMR Biomed 11:55-66.
27. Mamprin ME, Rodriguez JV, Guibert EE. 1995. Importance of pH in resuspension media on viability of hepatocytes preserved in University of Wisconsin solution. Cell Transplant 4:269-274.
28. Mizutani T. 1982. Adsorption of some antibiotics and other drugs on silicone-coated glass surfaces. J Pharm Pharmacol 34:608-609.
29. Nyberg SL, Remmel RP, Mann HJ, Peshwa MV, Hu W-S, Cerra FB. 1994. Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver. Ann Surg 220:59-67.
30. Olinga P, Merema M, Slooff MJH, Meijer DKF, Groothuis GMM. 1997. Influence of 48 hours cold storage in University of Wisconsin organ preservation solution on metabolic capacity of rat hepatocytes. J Hepatol 27:738-743.
31. Osuga T, Obata T, Ikehira H, Tanada S, Sasaki Y, Naito H. 1998. Dialysate pressure isobars in a hollow-fiber dialyzer determined from magnetic resonance imaging and numerical simulation of dialysate flow. Artif Organs 22:907-909.
32. Pascolo L, Cupelli F, Anelli PL, Lorusso V, Visigalli M, Uggeri F, Tiribelli C. 1999. Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents. Biochem Biophys Res Commun 257:746-752.
33. Pascolo L, Petrovic S, Cupelli F, Bruschi CV, Anelli PL, Lorusso V, Visigalli M, Uggeri F, Tiribelli C. 2001. ABC protein transport of MRI contrast agents in canalicular rat liver plasma vesicles and yeast vacuoles. Biochem Biophys Res Commun 282:60-66.
34. Patzer JF II. 2001. Advances in bioartificial liver assist devices. Ann NY Acad Sci 944:320-333.
35. Potter K, Butler JJ, Adams C, Fishbein KW, Mcfarland EW, Horton WE, Spencer RGS. 1998. Cartilage formation in a hollow fiber bioreactor studied by proton magnetic resonance microscopy. Matrix Biol 17: 513-523.
36. Reimer P, Bader A, Weissleder R. 1998. Preclinical assessment of hepatocyte-targeted MR contrast agents in stable human cell cultures. J Magn Reson Imag 8:687-689.
37. Rosen DA, Rosen KR, Silvasi DL. 1990. In vitro variability in fentanyl absorption by different membrane oxygenators. J Cardiothoracic Anesth 4:332-335.
38. Rotem A, Toner M, Tompkins RG, Yarmush ML. 1992. Oxygen uptake rates in cultures rat hepatocytes. Biotechnol Bioeng 40:1286-1291.
39. Rozga J, Williams F, Ro M-S, Neuzil DF, Giorgio TD, Backfisch G, Moscioni D, Hakim R, Demetriou AA. 1993. Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cells. Hepatology 17:258-265.
40. Sandker GW, Weert B, Slooff MJH, Groothuis GMM. 1990. Preservation of isolated rat and human hepatocytes in UW solution. Transplant Proc 22:2204-2205.
41. Sandker GW, Slooff MJH, Groothuis GMM. 1992. Drug transport, viability and morphology of isolated rat hepatocytes preserved for 24 hours in University of Wisconsin solution. Biochem Pharmacol 43:1479-1485.
42. Sasse D, Spornitz UM, Maly IP. 1992. Liver architecture. Enzyme 46:8-32.
43. Schmalbrock P, Hines JV, Lee S-M, Ammar GM, Kwok EW-C. 2001. T1 measurement in cell cultures: a new tool for characterizing contrast agents at 1.5T. J Magn Reson Imag 14:636-648.
44. Schulze E, Ferrucci JT, Poss K, Lapointe L, Bogdanova A, Weissleder R. 1995. Cellular uptake and trafficking of a prototype magnetic iron oxide label in vitro. Invest Radiol 30:604-610.
45. Seglen O. 1976. Preparation of isolated rat liver cells. In: Prescott DM, editor. Methods in cell biology. New York: Academic Press. p 29-83.
46. Semelka RC, Helmberger TKG. 2001. Contrast agents for MR imaging of the liver. Radiology 28:27-38.
47. Taylor HM, Ros PR. 1998. Hepatic imaging. Radiol Clin North Am 36:237-245.
48. Tharakan JP. 1986. Operation and pressure distribution of immobilized cell hollow fiber bioreactors. Biotechnol Bioeng 28:1064-1071.
49. Tze WJ, Tai J, Wong FC, Davis HR. 1980. Studies with implantable artificial capillary units containing rat islets on diabetic dogs. Diabetologica 19:541-545.
50. Van Montfoort JE, Stieger B, Meijer DKF, Weinmann H-J, Meier PJ, Fattinger KE. 1999. Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. J Pharmacol Exp Ther 290:153-157.
51. Weibel ER, Staubli W, Gnagi HR, Hess FA. 1969. Correlated morphometric and biochemical studies on the liver cell. J Cell Biol 42: 68-91.
52. Zhang J, Parker DL, Leypoldt JK. 1995. Flow distributions in hollow fiber hemodialyzers using magnetic resonance Fourier velocity imaging. ASAIO J 41:678-682.